Novozymes sell Biopharma Sweden operations Repligen Corp

Novozymes to sell Biopharma Sweden operations to Repligen Corp

11:50 PM, 6th November 2011
Novozymes to sell Biopharma Sweden operations to Repligen Corp
Dr Thomas Videbaek, Executive Vice President, BioBusiness, Novozymes.


BAGSVAERD, DENMARK: As agreed on October 27, Repligen Corp acquires Novozymes’ Biopharma Sweden activities. The transaction is expected to be finalized during the fourth quarter of 2011. The deal is a cash transaction of roughly DKK 125 million (€17 million) with contingent milestone payments of roughly DKK 30 million (€4 million), payable in 2012-2015.

Earlier this year Novozymes announced that the company has been looking for a potential spin off or divestment of its antimicrobial peptide (AMP) projects such as Plectasin and Arenicin.

The divestment allows for an even sharper focus on the increasing potential within many of BioBusiness’ key focus areas, including hyaluronic acid and rAlbumin products and technologies for pharmaceutical and medical device applications.

“The decision to discontinue the AMP projects has called for a review of the purpose of Novozymes Biopharma Sweden operations, which from the outset was mainly intended as a launch plant for drug discovery projects, including AMPs, but also for the production and development of Novozymes’ cell culture ingredient and Protein A products,” said Dr Thomas Videbaek, Executive Vice President, BioBusiness, Novozymes.

“Repligen is a strong buyer with strategic focus to strengthen their activities within the cell culture ingredient and affinity ligands business,” he added.

Thomas Videbaek stated that Novozymes ambition for BioBusiness of sales of DKK 6 billion in 2018 is still valid following the divestment. “Our other areas within Biopharma for the medical device and drug delivery & formulation markets are developing positively. These are areas within Novozymes that will remain in high focus,” he said.

(C) WOC News




Your Comments (Up to 2000 characters)
Please respect our community and the integrity of its participants. WOC reserves the right to moderate and approve your comment.

Related News

Fluor bags Luminant’s construction services contract in Texas

  IRVING, US: Fluor Corporation was awarded a multi-year special projects supplement to their existing contract to provide construction and othe ...

Read more
IFC invests in wind-power project in Pakistan

  ISTANBUL, TURKEY: IFC, a member of the World Bank Group, is investing $38.1 million in Zorlu Enerji Pakistan Ltd to support the construction o ...

Read more
FMC to acquire South Pole Biogroup in Chile

  PHILADELPHIA, US: FMC Corporation will acquire South Pole Biogroup Ltda, a Chilean-based natural colour and specialty nutrition ingredients ma ...

Read more
LyondellBasell prices $1 billion senior notes due 2021

  ROTTERDAM, NETHERLANDS: LyondellBasell Industries N V announced that it has priced its previously announced offering of $1billion aggregate pr ...

Read more
Could fish fossils help us better predict climate change?

MISSOURI, US: By measuring an element present in fish fossils, researchers at the University of Missouri may have found a key to better understanding ...

Read more
‘Artificial leaf’ makes fuel from sunlight

MASSACHUSETTS, US: Researchers led by MIT Professor Daniel Nocera have produced something they’re calling an “artificial leaf”: Like ...

Read more uses cookies to ensure that we give you the best experience on our website. By using this site, you agree to our Privacy Policy and our Terms of Use. X